An artificial intelligence (AI)-based method for interpreting ECGs performed better than standard approaches in detecting occlusive myocardial infarction (MI).

The U.S. Food and Drug Administration expanded the use of Rhythm Pharmaceuticals’  therapy for a rare form of obesity ​caused ...

We read with interest the results of the HARMONi-6 trial by Zhiwei Chen and colleagues,1 which showed that ivonescimab plus chemotherapy improved progression-free survival versus tislelizumab plus ...

The 2026 U.S. cholesterol guidelines urge starting screening and treatment at 30 to prevent cardiovascular disease ...

A blood pressure program adopted across the University of California's six academic medical centers has effectively lowered hypertension and prevented serious disease or death for thousands of ...

Freeman Heart & Vascular Institute has earned Level 1 STEMI designation from the Missouri Department of Health and Senior Services. Freeman Health System previously received Level 1 honors in 2017, ...

MRT-2359 is an investigational, orally bioavailable, GSPT1-directed molecular glue degrader that has shown compelling clinical activity in ...

The SCORE2 (Systematic Coronary Risk Evaluation 2) and PREVENT (AHA Predicting Risk of CVD Events) tools are risk-assessment calculators that have been recently developed and validated for individuals ...

February 17, 2026 — The Brain Trauma Foundation has updated the 2001 evidence-based guidelines for the care of patients with penetrating traumatic brain injury (pTBI). A working group of more than 30 ...

HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer ASCO Guidelines provide ...

Editor’s note: If you or someone you know is struggling with mental health, help is available. Dial or text 988 or visit 988lifeline.org for free and confidential support. Summer passed Valerie Zeko ...